In contrast, modern GLP-1 receptor agonists have shown cardiovascular benefits in high-risk patients
Both Retatrutide and Ozempic belong to the incretin-based therapy family, but they take fundamentally different approaches to metabolic modulation
Trial evidence for tirzepatide Tirzepatide's weight-management evidence comes chiefly from the SURMOUNT program, published in The New England Journal of Medicine in 2022, with SURMOUNT-OSA extending to obstructive sleep apnea in 2024
While these effects are beneficial, the adjustment period can temporarily affect your energy levelsespecially during the first few weeks of treatment or when your dosage increases
Although these medications contain the same active ingredient, their approved indications and dosing differ based on formulation and strength
281 A more recent study found that GLP-1R expression was increased in hepatocytes from non-alcoholic steatohepatitis liver samples in comparison to healthy livers, implying that GLP-1R signalling plays a role in liver pathology
